Combination analysis of immunohistochemistry (IHC) with high-throughput RNA sequencing (RNAseq), and microarray data from The Cancer Genome Atlas (TCGA), confirmed the relationship between CDK5 levels and progression of HCC [177]. Here, CDK5 is linked to hepatocellular carcinoma.